These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2996358)

  • 1. Production of a human monoclonal antibody to HLA by human-human hybridoma technology. A preliminary report.
    Hulette CM; Effros RB; Dillard LC; Walford RL
    Am J Pathol; 1985 Oct; 121(1):10-4. PubMed ID: 2996358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
    Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
    Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
    Kozbor D; Lagarde AE; Roder JC
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human myeloma cell line suitable for the generation of human monoclonal antibodies.
    Karpas A; Dremucheva A; Czepulkowski BH
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1799-804. PubMed ID: 11172031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
    Gustafsson B; Jondal M; Sundqvist VA
    Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antibodies against Mycobacterium leprae.
    Atlaw T; Kozbor D; Roder JC
    Infect Immun; 1985 Jul; 49(1):104-10. PubMed ID: 2989177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
    Yu X; McGraw PA; House FS; Crowe JE
    J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
    Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
    Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of ouabain-resistant human fusion partners.
    Ramachandra RN; Berczi I; Rector ES; Sehon AH
    J Immunol Methods; 1991 Aug; 142(1):21-9. PubMed ID: 1655911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18.
    Hansen T; Kolstad A; Thorsby E; Hannestad K
    Tissue Antigens; 1987 May; 29(5):246-56. PubMed ID: 2821654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.